There is a consensus on the importance of lowering blood cholesterol in individuals and populations.
To determine trends in the detection and treatment of elevated cholesterol, a series of studies known as the Minnesota Heart Survey evaluated cardiovascular disease, risk, and health behavior among adults in the upper Midwest between 1980 and 1992.
Over 25,000 adult residents of large and small communities were surveyed for information on risk factors and health habits, including status of cholesterol detection and treatment.
During those years, population levels of blood cholesterol declined significantly for both men and women, largely as the result of changes in diet.
Levels of clinical detection of hypercholesterolemia, initially low, also rose.
However, subjects who had been informed that they had increased lipids reported that recommendations from their physicians for dietary therapy declined, while recommendations for weight loss increased during the survey period.
Medication use for elevated blood cholesterol, always low, rose slightly, but many subjects discontinued medications due to side effects, the perception that their cholesterol was controlled, lack of perceived benefit, or cost.
A total of 274 primary care physicians were also surveyed.
Physicians reported that they screen more frequently than in the past and initiate drug therapy at a lower threshold. (...)
Mots-clés Pascal : Cholestérol, Dépistage, Etude cohorte, Minnesota, Etats Unis, Amérique du Nord, Amérique, Enquête, Evaluation, Appareil circulatoire pathologie, Relation médecin malade, Traitement diététique, Chimiothérapie, Communauté, Homme, Lipide, Métabolisme pathologie, Dyslipémie, Hyperlipoprotéinémie, Cardiopathie coronaire, Education santé, Politique sanitaire
Mots-clés Pascal anglais : Cholesterol, Medical screening, Cohort study, Minnesota, United States, North America, America, Survey, Evaluation, Cardiovascular disease, Physician patient relation, Diet therapy, Chemotherapy, Community, Human, Lipids, Metabolic diseases, Dyslipemia, Hyperlipoproteinemia, Coronary heart disease, Health education, Health policy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0234063
Code Inist : 002B22A. Création : 11/06/1997.